Table 2.
Title | Year | TC | Journal | First author |
---|---|---|---|---|
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease | 2012 | 2710 | Nature | Luke Jostins |
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatorybowel diseases | 2007 | 2599 | Proc Natl Acad Sci U S A | Daniel N. Frank |
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gutmicrobiota analysis of Crohn disease patients | 2008 | 2275 | Proc Natl Acad Sci U S A | Harry Sokol |
A microbial symbiosis factor prevents intestinal inflammatory disease | 2008 | 1439 | Nature | Sarkis K. Mazmanian |
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | 2012 | 1359 | Genome Biology | Xochitl C. Morgan |
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis | 2007 | 1341 | Nature Genetics | John D. Rioux |
Inducible Foxp(3+) regulatory T-cell development by a commensal bacterium of the intestinal microbiota | 2010 | 1231 | Proc Natl Acad Sci U S A | June L. Round |
Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine | 2008 | 1101 | Cell Host & Microbe | Ivaylo I. Ivanov |
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota | 2012 | 1076 | Science | Janelle C. Arthur |
Mucosal microbiota in inflammatory bowel disease | 2002 | 994 | Gastroenterology | Alexander Swidsinski |
TC: total citations.